WPD Pharmaceuticals Inc. (WPDPF)

USD 0.0

(0.0%)

Long Term Debt Summary of WPD Pharmaceuticals Inc.

  • WPD Pharmaceuticals Inc.'s latest annual long term debt in 2023 was 229.29 Thousand USD , down 0.0% from previous year.
  • WPD Pharmaceuticals Inc.'s latest quarterly long term debt in 2024 Q2 was 249 Thousand USD , up 5.84% from previous quarter.
  • WPD Pharmaceuticals Inc. reported annual long term debt of - USD in 2022, down 0.0% from previous year.
  • WPD Pharmaceuticals Inc. reported annual long term debt of - USD in 2021, down 0.0% from previous year.
  • WPD Pharmaceuticals Inc. reported quarterly long term debt of 249 Thousand USD for 2024 Q2, up 5.84% from previous quarter.
  • WPD Pharmaceuticals Inc. reported quarterly long term debt of 229.29 Thousand USD for 2023 Q4, up 9.97% from previous quarter.

Annual Long Term Debt Chart of WPD Pharmaceuticals Inc. (2023 - 2014)

Historical Annual Long Term Debt of WPD Pharmaceuticals Inc. (2023 - 2014)

Year Long Term Debt Long Term Debt Growth
2023 229.29 Thousand USD 0.0%
2022 - USD 0.0%
2021 - USD 0.0%
2020 - USD 0.0%
2019 - CAD 0.0%
2018 - USD -100.0%
2017 7381.51 USD -80.34%
2016 37.55 Thousand USD 0.0%
2015 - USD 0.0%
2014 - USD 0.0%

Peer Long Term Debt Comparison of WPD Pharmaceuticals Inc.

Name Long Term Debt Long Term Debt Difference
Burzynski Research Institute, Inc. - USD -Infinity%
Arch Therapeutics, Inc. - USD -Infinity%
Evofem Biosciences, Inc. 8000.00 USD -2766.138%
Nascent Biotech, Inc. - USD -Infinity%
Rebus Holdings, Inc. - USD -Infinity%
Santhera Pharmaceuticals Holding AG 1.75 Million USD 86.939%
Qrons Inc. 80 Thousand USD -186.614%
Adynxx, Inc. - USD -Infinity%
Neon Bloom, Inc. - USD -Infinity%
Northwest Biotherapeutics, Inc. 20.31 Million USD 98.871%
ProtoKinetix, Incorporated - USD -Infinity%
Skye Bioscience, Inc. 171.23 Thousand USD -33.908%
Eiger BioPharmaceuticals, Inc. - USD -Infinity%
Nanobac Pharmaceuticals, Incorporated - USD -Infinity%
Institute of Biomedical Research Corp. - USD -Infinity%
SQZ Biotechnologies Company 20.9 Million USD 98.903%
Intellipharmaceutics International Inc. - USD -Infinity%
Propanc Biopharma, Inc. 58.64 Thousand USD -291.001%
Mesoblast Limited 100.29 Million USD 99.771%
Marizyme, Inc. 667.12 Thousand USD 65.63%
Genus plc 228.2 Million USD 99.9%
VioQuest Pharmaceuticals, Inc. - USD -Infinity%
Pharming Group N.V. 166.1 Million USD 99.862%
Therapeutic Solutions International, Inc. 5512.00 USD -4059.851%
CNBX Pharmaceuticals Inc. - USD -Infinity%
Nymox Pharmaceutical Corporation - USD -Infinity%
ContraFect Corporation 2.21 Million USD 89.625%
PsyBio Therapeutics Corp. - USD -Infinity%
Sienna Biopharmaceuticals, Inc. - USD -Infinity%
RegeneRx Biopharmaceuticals, Inc. 1.4 Million USD 83.656%
IMV Inc. 27.39 Million USD 99.163%
AXIM Biotechnologies, Inc. 5.42 Million USD 95.775%
MultiCell Technologies, Inc. 36.43 USD -629301.592%
ONE Bio Corp. 592.19 Thousand USD 61.281%
Accustem Sciences Inc. - USD -Infinity%
RVL Pharmaceuticals plc 55.61 Million USD 99.588%
Arno Therapeutics, Inc. - USD -Infinity%
EV Biologics, Inc. - USD -Infinity%
Q BioMed Inc. - USD -Infinity%
Emmaus Life Sciences, Inc. 2.22 Million USD 89.699%
Mosaic ImmunoEngineering Inc. 1.22 Million USD 81.334%
Biomind Labs Inc. - USD -Infinity%
American Oriental Bioengineering, Inc. 554.59 Thousand USD 58.656%
Provectus Biopharmaceuticals, Inc. 25.29 Thousand USD -806.324%
TetraLogic Pharmaceuticals Corporation - USD -Infinity%
Oncotelic Therapeutics, Inc. 1.89 Million USD 87.922%
GlobeStar Therapeutics Corporation - USD -Infinity%
THC Farmaceuticals, Inc. - USD -Infinity%
Acro Biomedical Co., Ltd. - USD -Infinity%
Curative Biotechnology, Inc. - USD -Infinity%
GB Sciences, Inc. 322 Thousand USD 28.792%
Alpha Cognition Inc. - USD -Infinity%
HST Global, Inc. - USD -Infinity%
CSL Limited 11.23 Billion USD 99.998%
Wesana Health Holdings Inc. - USD -Infinity%
Halberd Corporation 150 Thousand USD -52.861%
Enzolytics Inc. - USD -Infinity%
Agentix Corp. - USD -Infinity%
Resverlogix Corp. - USD -Infinity%
Nuo Therapeutics, Inc. 164.2 Thousand USD -39.637%
MetaStat, Inc. - USD -Infinity%
argenx SE 15.35 Million USD 98.507%
Enzon Pharmaceuticals, Inc. - USD -Infinity%
Endonovo Therapeutics, Inc. - USD -Infinity%
RespireRx Pharmaceuticals Inc. - USD -Infinity%
GeneThera, Inc. - USD -Infinity%
Inhibitor Therapeutics, Inc. - USD -Infinity%
AVAX Technologies, Inc. - USD -Infinity%
Zenith Capital Corp. 4456.00 USD -5045.669%
Genscript Biotech Corporation 287.12 Million USD 99.92%
Ember Therapeutics, Inc. - USD -Infinity%
Anthera Pharmaceuticals, Inc. - USD -Infinity%
Sigyn Therapeutics, Inc. 126.3 Thousand USD -81.542%
Cotinga Pharmaceuticals Inc. - USD -Infinity%
Kadimastem Ltd 229.69 Thousand USD 0.174%
Helix BioMedix, Inc. - USD -Infinity%
VitaSpring Biomedical Co. Ltd. - USD -Infinity%
Capstone Therapeutics Corp. 8.26 Million USD 97.225%
BioStem Technologies, Inc. 265.63 Thousand USD 13.682%
Oncology Pharma Inc. - USD -Infinity%
Reve Technologies, Inc. 1064.00 USD -21449.906%
LadRx Corporation - USD -Infinity%
Cell Source, Inc. - USD -Infinity%
Regen BioPharma, Inc. 149.61 Thousand USD -53.255%
Regen BioPharma, Inc. 149.61 Thousand USD -53.255%
NovAccess Global Inc. - USD -Infinity%
Affymax, Inc. - USD -Infinity%
Itoco Inc. - USD -Infinity%
Rasna Therapeutics, Inc. - USD -Infinity%
Pathfinder Cell Therapy, Inc. - USD -Infinity%
Mobile Lads Corp. - USD -Infinity%
CytoDyn Inc. 141 Thousand USD -62.618%
Claritas Pharmaceuticals, Inc. - USD -Infinity%
NDT Pharmaceuticals Inc. - USD -Infinity%
NanoSphere Health Sciences Inc. - USD -Infinity%
Alseres Pharmaceuticals, Inc. 7.81 Million USD 97.068%
SYBLEU INC 300 Thousand USD 23.57%
Advanced Proteome Therapeutics Corporation - USD -Infinity%
ImmunoCellular Therapeutics, Ltd. 369.04 Thousand USD 37.87%
International Stem Cell Corporation 445 Thousand USD 48.474%
Bioxytran, Inc. - USD -Infinity%
GlobeImmune, Inc. - USD -Infinity%
Predictive Technology Group, Inc. - USD -Infinity%
ProText Mobility, Inc. - USD -Infinity%
Cardax, Inc. - USD -Infinity%
VG Life Sciences Inc. - USD -Infinity%
Kaleido Biosciences, Inc. - USD -Infinity%
Advaxis, Inc. 8.15 Million USD 97.187%
Adhera Therapeutics, Inc. - USD -Infinity%
RenovaCare, Inc. - USD -Infinity%
Regnum Corp. - USD -Infinity%
Innovation Pharmaceuticals Inc. 457 Thousand USD 49.827%
Neutra Corp. - USD -Infinity%
Windtree Therapeutics, Inc. 1.16 Million USD 80.251%
PureTech Health plc 18.25 Million USD 98.744%
Coeptis Therapeutics, Inc. 150 Thousand USD -52.861%
IXICO plc 275 Thousand USD 16.621%
IntelGenx Technologies Corp. 11.83 Million USD 98.063%
Gelesis Holdings, Inc. 26.3 Million USD 99.128%
CSL Limited 11.23 Billion USD 99.998%
Cellectis S.A. 36.21 Million USD 99.367%